is tirzepatide going off market Concerns Surrounding Compounded GLP-1s Mount As Shortages of Tirzepatide, Semaglutide End The FDA says the Zepbound

Its dual-action mechanism operates on two separate receptor pathways simultaneously, which has practical implications for how injection site selection impacts your results

Massive Pharmaceutical Investments The world's largest pharmaceutical companies are investing billions of dollars into GLP-1 development and manufacturing

This would not reduce your risk and might increase it

And if you subscribe, the cost difference is even starker since the price drops to $18.68 and you get free shipping

Semaglutide was first developed for type 2 diabetes management, where clinical trials showed it improved blood sugar control in patients who also experienced significant weight loss